PreveCeutical Medical Inc. (Preveceutical Medical Inc. R) aksje
18H0.F
Forsinket 15 minPreveceutical Medical Inc. R
Market Cap
$7,178,243
Om PreveCeutical Medical Inc. (Preveceutical Medical Inc. R) aksje
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). The company is headquartered in West Vancouver, Canada.
Selskapsinformasjon
V7W 2R2 West Vancouver, Canada
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.